Antimicrobial activity of rhodium (I) and ruthenium (II) carbene complexes derived from benzimidazole against Staphylococcus aureus isolates

dc.contributor.author	Durmaz, R.
dc.contributor.author	Kucukbay, H.
dc.contributor.author	Cetinkaya, E.
dc.contributor.author	Cetinkaya, B.
dc.date.accessioned	2022-10-06T09:37:22Z
dc.date.available	2022-10-06T09:37:22Z
dc.date.issued	1997
dc.identifier.issn	13000144 (ISSN)
dc.identifier.uri	http://hdl.handle.net/11616/63004
dc.description.abstract	As an extension of our previous study, three benzimidazole derivatives and one benzothiazolium salt found to be significantly effective against Staphylococcus aureus (ATCC 29213) were evaluated for their in vitro antimicrobial activity againts 98 Staphylococcus strains isolated from the nasal swabs of hospital staff (68) and clinical specimens (30). The previously synthesized compounds, referred to as 1, 2, 3 and 4, were found to be effective at the average minimal inhibitory concentrations (MICs) of 5.8, 5.5, 18.5 and 15.8 μg/mL, respectively. The results of this study show the activity of compounds 1 and 2 against staphylococci to be noteworthy.
dc.source	Turkish Journal of Medical Sciences
dc.title	Antimicrobial activity of rhodium (I) and ruthenium (II) carbene complexes derived from benzimidazole against Staphylococcus aureus isolates

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.